Medartis Holding AG
Medartis Holding AG (MDRSF) Stock Competitors & Peer Comparison
See (MDRSF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDRSF | $100.00 | -1.97% | 1.2B | -1666.67 | -$0.06 | N/A |
| SMMNY | $24.74 | +1.38% | 111.2B | 22.06 | $1.12 | +1.49% |
| SEMHF | $50.45 | -1.56% | 56.3B | 22.52 | $2.24 | +2.34% |
| RYLPF | $31.47 | -4.64% | 29.9B | 27.85 | $1.13 | +3.04% |
| SONVY | $50.07 | +0.06% | 14.9B | 22.15 | $2.26 | +2.15% |
| SONVF | $249.59 | -0.16% | 14.9B | 22.13 | $11.28 | +2.18% |
| SNNUF | $16.59 | +0.00% | 14.1B | 29.62 | $0.56 | +2.30% |
| CHEOF | $180.67 | +0.00% | 11.8B | 43.96 | $4.11 | +1.53% |
| CHEOY | $68.35 | -0.87% | 8.9B | 36.48 | $1.87 | +1.92% |
| WILYY | $13.84 | -8.28% | 6.1B | 15.55 | $0.89 | N/A |
Stock Comparison
MDRSF vs SMMNY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, SMMNY has a market cap of 111.2B. Regarding current trading prices, MDRSF is priced at $100.00, while SMMNY trades at $24.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas SMMNY's P/E ratio is 22.06. In terms of profitability, MDRSF's ROE is -0.00%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, MDRSF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check SMMNY's competition here
MDRSF vs SEMHF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, SEMHF has a market cap of 56.3B. Regarding current trading prices, MDRSF is priced at $100.00, while SEMHF trades at $50.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas SEMHF's P/E ratio is 22.52. In terms of profitability, MDRSF's ROE is -0.00%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, MDRSF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check SEMHF's competition here
MDRSF vs RYLPF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, RYLPF has a market cap of 29.9B. Regarding current trading prices, MDRSF is priced at $100.00, while RYLPF trades at $31.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas RYLPF's P/E ratio is 27.85. In terms of profitability, MDRSF's ROE is -0.00%, compared to RYLPF's ROE of +0.08%. Regarding short-term risk, MDRSF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check RYLPF's competition here
MDRSF vs SONVY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, SONVY has a market cap of 14.9B. Regarding current trading prices, MDRSF is priced at $100.00, while SONVY trades at $50.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas SONVY's P/E ratio is 22.15. In terms of profitability, MDRSF's ROE is -0.00%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, MDRSF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check SONVY's competition here
MDRSF vs SONVF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, SONVF has a market cap of 14.9B. Regarding current trading prices, MDRSF is priced at $100.00, while SONVF trades at $249.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas SONVF's P/E ratio is 22.13. In terms of profitability, MDRSF's ROE is -0.00%, compared to SONVF's ROE of +0.18%. Regarding short-term risk, MDRSF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check SONVF's competition here
MDRSF vs SNNUF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, SNNUF has a market cap of 14.1B. Regarding current trading prices, MDRSF is priced at $100.00, while SNNUF trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas SNNUF's P/E ratio is 29.62. In terms of profitability, MDRSF's ROE is -0.00%, compared to SNNUF's ROE of +0.09%. Regarding short-term risk, MDRSF is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check SNNUF's competition here
MDRSF vs CHEOF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CHEOF has a market cap of 11.8B. Regarding current trading prices, MDRSF is priced at $100.00, while CHEOF trades at $180.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CHEOF's P/E ratio is 43.96. In terms of profitability, MDRSF's ROE is -0.00%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, MDRSF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check CHEOF's competition here
MDRSF vs CHEOY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CHEOY has a market cap of 8.9B. Regarding current trading prices, MDRSF is priced at $100.00, while CHEOY trades at $68.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CHEOY's P/E ratio is 36.48. In terms of profitability, MDRSF's ROE is -0.00%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, MDRSF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check CHEOY's competition here
MDRSF vs WILYY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, WILYY has a market cap of 6.1B. Regarding current trading prices, MDRSF is priced at $100.00, while WILYY trades at $13.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas WILYY's P/E ratio is 15.55. In terms of profitability, MDRSF's ROE is -0.00%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, MDRSF is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check WILYY's competition here
MDRSF vs GNGBY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, GNGBY has a market cap of 6B. Regarding current trading prices, MDRSF is priced at $100.00, while GNGBY trades at $21.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas GNGBY's P/E ratio is 23.63. In terms of profitability, MDRSF's ROE is -0.00%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, MDRSF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check GNGBY's competition here
MDRSF vs WILLF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, WILLF has a market cap of 6B. Regarding current trading prices, MDRSF is priced at $100.00, while WILLF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas WILLF's P/E ratio is 15.86. In terms of profitability, MDRSF's ROE is -0.00%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, MDRSF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check WILLF's competition here
MDRSF vs GNGBF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, MDRSF is priced at $100.00, while GNGBF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, MDRSF's ROE is -0.00%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, MDRSF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check GNGBF's competition here
MDRSF vs NHNKY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, NHNKY has a market cap of 3.7B. Regarding current trading prices, MDRSF is priced at $100.00, while NHNKY trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas NHNKY's P/E ratio is 16.20. In terms of profitability, MDRSF's ROE is -0.00%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, MDRSF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check NHNKY's competition here
MDRSF vs AMBFF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, AMBFF has a market cap of 3.7B. Regarding current trading prices, MDRSF is priced at $100.00, while AMBFF trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas AMBFF's P/E ratio is 42.66. In terms of profitability, MDRSF's ROE is -0.00%, compared to AMBFF's ROE of +0.09%. Regarding short-term risk, MDRSF is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check AMBFF's competition here
MDRSF vs AMBBY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, AMBBY has a market cap of 3.3B. Regarding current trading prices, MDRSF is priced at $100.00, while AMBBY trades at $12.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas AMBBY's P/E ratio is 39.19. In terms of profitability, MDRSF's ROE is -0.00%, compared to AMBBY's ROE of +0.09%. Regarding short-term risk, MDRSF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check AMBBY's competition here
MDRSF vs MCRPF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, MCRPF has a market cap of 2.9B. Regarding current trading prices, MDRSF is priced at $100.00, while MCRPF trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas MCRPF's P/E ratio is -17.44. In terms of profitability, MDRSF's ROE is -0.00%, compared to MCRPF's ROE of -0.27%. Regarding short-term risk, MDRSF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check MCRPF's competition here
MDRSF vs NHNKF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, NHNKF has a market cap of 2.4B. Regarding current trading prices, MDRSF is priced at $100.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, MDRSF's ROE is -0.00%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, MDRSF is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check NHNKF's competition here
MDRSF vs GGNDF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, GGNDF has a market cap of 2.4B. Regarding current trading prices, MDRSF is priced at $100.00, while GGNDF trades at $16.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas GGNDF's P/E ratio is 23.15. In terms of profitability, MDRSF's ROE is -0.00%, compared to GGNDF's ROE of +0.06%. Regarding short-term risk, MDRSF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check GGNDF's competition here
MDRSF vs GNNDY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, MDRSF is priced at $100.00, while GNNDY trades at $43.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas GNNDY's P/E ratio is 20.25. In terms of profitability, MDRSF's ROE is -0.00%, compared to GNNDY's ROE of +0.06%. Regarding short-term risk, MDRSF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check GNNDY's competition here
MDRSF vs DRWKF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, MDRSF is priced at $100.00, while DRWKF trades at $111.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas DRWKF's P/E ratio is 14.57. In terms of profitability, MDRSF's ROE is -0.00%, compared to DRWKF's ROE of +0.08%. Regarding short-term risk, MDRSF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check DRWKF's competition here
MDRSF vs OSSFF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, OSSFF has a market cap of 2.1B. Regarding current trading prices, MDRSF is priced at $100.00, while OSSFF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas OSSFF's P/E ratio is 24.25. In terms of profitability, MDRSF's ROE is -0.00%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, MDRSF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check OSSFF's competition here
MDRSF vs OSSUY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, OSSUY has a market cap of 1.9B. Regarding current trading prices, MDRSF is priced at $100.00, while OSSUY trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas OSSUY's P/E ratio is 22.30. In terms of profitability, MDRSF's ROE is -0.00%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, MDRSF is less volatile compared to OSSUY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check OSSUY's competition here
MDRSF vs DWRKF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, MDRSF is priced at $100.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, MDRSF's ROE is -0.00%, compared to DWRKF's ROE of N/A. Regarding short-term risk, MDRSF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check DWRKF's competition here
MDRSF vs MEDGF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, MDRSF is priced at $100.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, MDRSF's ROE is -0.00%, compared to MEDGF's ROE of +0.24%. Regarding short-term risk, MDRSF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check MEDGF's competition here
MDRSF vs STSEY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, STSEY has a market cap of 1.5B. Regarding current trading prices, MDRSF is priced at $100.00, while STSEY trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas STSEY's P/E ratio is 17.00. In terms of profitability, MDRSF's ROE is -0.00%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, MDRSF is less volatile compared to STSEY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check STSEY's competition here
MDRSF vs DGWPF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, MDRSF is priced at $100.00, while DGWPF trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas DGWPF's P/E ratio is 9.45. In terms of profitability, MDRSF's ROE is -0.00%, compared to DGWPF's ROE of +0.08%. Regarding short-term risk, MDRSF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check DGWPF's competition here
MDRSF vs ELEAF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, MDRSF is priced at $100.00, while ELEAF trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ELEAF's P/E ratio is 21.28. In terms of profitability, MDRSF's ROE is -0.00%, compared to ELEAF's ROE of +0.09%. Regarding short-term risk, MDRSF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ELEAF's competition here
MDRSF vs VTRLY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, VTRLY has a market cap of 1.3B. Regarding current trading prices, MDRSF is priced at $100.00, while VTRLY trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas VTRLY's P/E ratio is -2.32. In terms of profitability, MDRSF's ROE is -0.00%, compared to VTRLY's ROE of -0.42%. Regarding short-term risk, MDRSF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check VTRLY's competition here
MDRSF vs FDMDF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, FDMDF has a market cap of 1.2B. Regarding current trading prices, MDRSF is priced at $100.00, while FDMDF trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas FDMDF's P/E ratio is -21.90. In terms of profitability, MDRSF's ROE is -0.00%, compared to FDMDF's ROE of -0.48%. Regarding short-term risk, MDRSF is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check FDMDF's competition here
MDRSF vs LFTSF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, MDRSF is priced at $100.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, MDRSF's ROE is -0.00%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, MDRSF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check LFTSF's competition here
MDRSF vs XVIPF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, XVIPF has a market cap of 740.9M. Regarding current trading prices, MDRSF is priced at $100.00, while XVIPF trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas XVIPF's P/E ratio is 261.33. In terms of profitability, MDRSF's ROE is -0.00%, compared to XVIPF's ROE of +0.01%. Regarding short-term risk, MDRSF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check XVIPF's competition here
MDRSF vs IOBCF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, IOBCF has a market cap of 533.7M. Regarding current trading prices, MDRSF is priced at $100.00, while IOBCF trades at $18.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas IOBCF's P/E ratio is 26.78. In terms of profitability, MDRSF's ROE is -0.00%, compared to IOBCF's ROE of +0.15%. Regarding short-term risk, MDRSF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check IOBCF's competition here
MDRSF vs AVMR Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, MDRSF is priced at $100.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas AVMR's P/E ratio is -18.34. In terms of profitability, MDRSF's ROE is -0.00%, compared to AVMR's ROE of -0.68%. Regarding short-term risk, MDRSF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check AVMR's competition here
MDRSF vs CALZF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CALZF has a market cap of 472.9M. Regarding current trading prices, MDRSF is priced at $100.00, while CALZF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CALZF's P/E ratio is 68.45. In terms of profitability, MDRSF's ROE is -0.00%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, MDRSF is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check CALZF's competition here
MDRSF vs BRSYF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, BRSYF has a market cap of 451.7M. Regarding current trading prices, MDRSF is priced at $100.00, while BRSYF trades at $11.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas BRSYF's P/E ratio is 72.13. In terms of profitability, MDRSF's ROE is -0.00%, compared to BRSYF's ROE of +0.09%. Regarding short-term risk, MDRSF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check BRSYF's competition here
MDRSF vs CSSPF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CSSPF has a market cap of 384.5M. Regarding current trading prices, MDRSF is priced at $100.00, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, MDRSF's ROE is -0.00%, compared to CSSPF's ROE of +0.08%. Regarding short-term risk, MDRSF is more volatile compared to CSSPF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check CSSPF's competition here
MDRSF vs CLVSF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CLVSF has a market cap of 378M. Regarding current trading prices, MDRSF is priced at $100.00, while CLVSF trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CLVSF's P/E ratio is 22.01. In terms of profitability, MDRSF's ROE is -0.00%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, MDRSF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check CLVSF's competition here
MDRSF vs CYBQY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CYBQY has a market cap of 362M. Regarding current trading prices, MDRSF is priced at $100.00, while CYBQY trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CYBQY's P/E ratio is -203.00. In terms of profitability, MDRSF's ROE is -0.00%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, MDRSF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check CYBQY's competition here
MDRSF vs HYBT Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, MDRSF is priced at $100.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas HYBT's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is -0.00%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, MDRSF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check HYBT's competition here
MDRSF vs DMTRF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, DMTRF has a market cap of 284.9M. Regarding current trading prices, MDRSF is priced at $100.00, while DMTRF trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas DMTRF's P/E ratio is -118.50. In terms of profitability, MDRSF's ROE is -0.00%, compared to DMTRF's ROE of +0.00%. Regarding short-term risk, MDRSF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check DMTRF's competition here
MDRSF vs CYBQF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CYBQF has a market cap of 261.5M. Regarding current trading prices, MDRSF is priced at $100.00, while CYBQF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CYBQF's P/E ratio is -196.00. In terms of profitability, MDRSF's ROE is -0.00%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, MDRSF is less volatile compared to CYBQF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check CYBQF's competition here
MDRSF vs HTLZF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, MDRSF is priced at $100.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, MDRSF's ROE is -0.00%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, MDRSF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check HTLZF's competition here
MDRSF vs EAPIF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, EAPIF has a market cap of 241.8M. Regarding current trading prices, MDRSF is priced at $100.00, while EAPIF trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas EAPIF's P/E ratio is -1.64. In terms of profitability, MDRSF's ROE is -0.00%, compared to EAPIF's ROE of -0.13%. Regarding short-term risk, MDRSF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check EAPIF's competition here
MDRSF vs IMPZY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, IMPZY has a market cap of 200.8M. Regarding current trading prices, MDRSF is priced at $100.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, MDRSF's ROE is -0.00%, compared to IMPZY's ROE of +15.11%. Regarding short-term risk, MDRSF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check IMPZY's competition here
MDRSF vs VMTHF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, VMTHF has a market cap of 184.7M. Regarding current trading prices, MDRSF is priced at $100.00, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas VMTHF's P/E ratio is -2.01. In terms of profitability, MDRSF's ROE is -0.00%, compared to VMTHF's ROE of -0.30%. Regarding short-term risk, MDRSF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check VMTHF's competition here
MDRSF vs DTXMF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, MDRSF is priced at $100.00, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, MDRSF's ROE is -0.00%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, MDRSF is more volatile compared to DTXMF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check DTXMF's competition here
MDRSF vs PXMBF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, PXMBF has a market cap of 149.9M. Regarding current trading prices, MDRSF is priced at $100.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, MDRSF's ROE is -0.00%, compared to PXMBF's ROE of +0.01%. Regarding short-term risk, MDRSF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check PXMBF's competition here
MDRSF vs EKDHF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, EKDHF has a market cap of 146.8M. Regarding current trading prices, MDRSF is priced at $100.00, while EKDHF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas EKDHF's P/E ratio is 16.99. In terms of profitability, MDRSF's ROE is -0.00%, compared to EKDHF's ROE of +0.08%. Regarding short-term risk, MDRSF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check EKDHF's competition here
MDRSF vs CLLKF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CLLKF has a market cap of 123.3M. Regarding current trading prices, MDRSF is priced at $100.00, while CLLKF trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CLLKF's P/E ratio is -0.90. In terms of profitability, MDRSF's ROE is -0.00%, compared to CLLKF's ROE of -0.50%. Regarding short-term risk, MDRSF is less volatile compared to CLLKF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check CLLKF's competition here
MDRSF vs AMEUF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, MDRSF is priced at $100.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, MDRSF's ROE is -0.00%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, MDRSF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check AMEUF's competition here
MDRSF vs SOMNF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, SOMNF has a market cap of 111.4M. Regarding current trading prices, MDRSF is priced at $100.00, while SOMNF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas SOMNF's P/E ratio is -51.00. In terms of profitability, MDRSF's ROE is -0.00%, compared to SOMNF's ROE of -0.07%. Regarding short-term risk, MDRSF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check SOMNF's competition here
MDRSF vs BCCOY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, BCCOY has a market cap of 105.9M. Regarding current trading prices, MDRSF is priced at $100.00, while BCCOY trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas BCCOY's P/E ratio is -0.75. In terms of profitability, MDRSF's ROE is -0.00%, compared to BCCOY's ROE of -0.50%. Regarding short-term risk, MDRSF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check BCCOY's competition here
MDRSF vs AVHHL Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, AVHHL has a market cap of 99.4M. Regarding current trading prices, MDRSF is priced at $100.00, while AVHHL trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas AVHHL's P/E ratio is -2.22. In terms of profitability, MDRSF's ROE is -0.00%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, MDRSF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check AVHHL's competition here
MDRSF vs JMDMF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, MDRSF is priced at $100.00, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, MDRSF's ROE is -0.00%, compared to JMDMF's ROE of N/A. Regarding short-term risk, MDRSF is more volatile compared to JMDMF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check JMDMF's competition here
MDRSF vs RSHUF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, MDRSF is priced at $100.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, MDRSF's ROE is -0.00%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, MDRSF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RSHUF's competition here
MDRSF vs CKMTF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, MDRSF is priced at $100.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, MDRSF's ROE is -0.00%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, MDRSF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check CKMTF's competition here
MDRSF vs SNZZF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, SNZZF has a market cap of 84.1M. Regarding current trading prices, MDRSF is priced at $100.00, while SNZZF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas SNZZF's P/E ratio is -5.35. In terms of profitability, MDRSF's ROE is -0.00%, compared to SNZZF's ROE of -0.41%. Regarding short-term risk, MDRSF is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check SNZZF's competition here
MDRSF vs BLOZF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, BLOZF has a market cap of 52.2M. Regarding current trading prices, MDRSF is priced at $100.00, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas BLOZF's P/E ratio is -10.77. In terms of profitability, MDRSF's ROE is -0.00%, compared to BLOZF's ROE of -2.60%. Regarding short-term risk, MDRSF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check BLOZF's competition here
MDRSF vs TLTFF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, TLTFF has a market cap of 49.5M. Regarding current trading prices, MDRSF is priced at $100.00, while TLTFF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas TLTFF's P/E ratio is -19.26. In terms of profitability, MDRSF's ROE is -0.00%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, MDRSF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check TLTFF's competition here
MDRSF vs BRNHF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, MDRSF is priced at $100.00, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, MDRSF's ROE is -0.00%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, MDRSF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check BRNHF's competition here
MDRSF vs RDGL Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, RDGL has a market cap of 38.6M. Regarding current trading prices, MDRSF is priced at $100.00, while RDGL trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas RDGL's P/E ratio is -8.50. In terms of profitability, MDRSF's ROE is -0.00%, compared to RDGL's ROE of -1.18%. Regarding short-term risk, MDRSF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RDGL's competition here
MDRSF vs POSC Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, POSC has a market cap of 35.1M. Regarding current trading prices, MDRSF is priced at $100.00, while POSC trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas POSC's P/E ratio is 0.41. In terms of profitability, MDRSF's ROE is -0.00%, compared to POSC's ROE of -3.78%. Regarding short-term risk, MDRSF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check POSC's competition here
MDRSF vs NVYTF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, NVYTF has a market cap of 33.9M. Regarding current trading prices, MDRSF is priced at $100.00, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, MDRSF's ROE is -0.00%, compared to NVYTF's ROE of -0.73%. Regarding short-term risk, MDRSF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check NVYTF's competition here
MDRSF vs GTHP Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, GTHP has a market cap of 32.6M. Regarding current trading prices, MDRSF is priced at $100.00, while GTHP trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas GTHP's P/E ratio is -7.80. In terms of profitability, MDRSF's ROE is -0.00%, compared to GTHP's ROE of +0.70%. Regarding short-term risk, MDRSF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check GTHP's competition here
MDRSF vs IPDQF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, IPDQF has a market cap of 28.5M. Regarding current trading prices, MDRSF is priced at $100.00, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas IPDQF's P/E ratio is -1.40. In terms of profitability, MDRSF's ROE is -0.00%, compared to IPDQF's ROE of -0.88%. Regarding short-term risk, MDRSF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check IPDQF's competition here
MDRSF vs MKEAF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, MDRSF is priced at $100.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, MDRSF's ROE is -0.00%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, MDRSF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check MKEAF's competition here
MDRSF vs KBBTF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, MDRSF is priced at $100.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, MDRSF's ROE is -0.00%, compared to KBBTF's ROE of N/A. Regarding short-term risk, MDRSF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check KBBTF's competition here
MDRSF vs PYNKF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, PYNKF has a market cap of 21.8M. Regarding current trading prices, MDRSF is priced at $100.00, while PYNKF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas PYNKF's P/E ratio is 3.42. In terms of profitability, MDRSF's ROE is -0.00%, compared to PYNKF's ROE of -2.30%. Regarding short-term risk, MDRSF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check PYNKF's competition here
MDRSF vs EMITF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, EMITF has a market cap of 20.1M. Regarding current trading prices, MDRSF is priced at $100.00, while EMITF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas EMITF's P/E ratio is -8.57. In terms of profitability, MDRSF's ROE is -0.00%, compared to EMITF's ROE of -0.14%. Regarding short-term risk, MDRSF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check EMITF's competition here
MDRSF vs DIZTF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, MDRSF is priced at $100.00, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, MDRSF's ROE is -0.00%, compared to DIZTF's ROE of -0.72%. Regarding short-term risk, MDRSF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check DIZTF's competition here
MDRSF vs ASAPF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ASAPF has a market cap of 16.3M. Regarding current trading prices, MDRSF is priced at $100.00, while ASAPF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ASAPF's P/E ratio is -20.94. In terms of profitability, MDRSF's ROE is -0.00%, compared to ASAPF's ROE of -0.32%. Regarding short-term risk, MDRSF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check ASAPF's competition here
MDRSF vs VPTDF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, VPTDF has a market cap of 13.9M. Regarding current trading prices, MDRSF is priced at $100.00, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas VPTDF's P/E ratio is -4.05. In terms of profitability, MDRSF's ROE is -0.00%, compared to VPTDF's ROE of +1.07%. Regarding short-term risk, MDRSF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check VPTDF's competition here
MDRSF vs TMDIF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, MDRSF is priced at $100.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, MDRSF's ROE is -0.00%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, MDRSF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check TMDIF's competition here
MDRSF vs ATBPF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, MDRSF is priced at $100.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, MDRSF's ROE is -0.00%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, MDRSF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ATBPF's competition here
MDRSF vs LXXGF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, MDRSF is priced at $100.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, MDRSF's ROE is -0.00%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, MDRSF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check LXXGF's competition here
MDRSF vs RMSL Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, RMSL has a market cap of 10.7M. Regarding current trading prices, MDRSF is priced at $100.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas RMSL's P/E ratio is 0.66. In terms of profitability, MDRSF's ROE is -0.00%, compared to RMSL's ROE of -12.31%. Regarding short-term risk, MDRSF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RMSL's competition here
MDRSF vs ALRTF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ALRTF has a market cap of 9M. Regarding current trading prices, MDRSF is priced at $100.00, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ALRTF's P/E ratio is -0.35. In terms of profitability, MDRSF's ROE is -0.00%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, MDRSF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check ALRTF's competition here
MDRSF vs PLLWF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, MDRSF is priced at $100.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, MDRSF's ROE is -0.00%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, MDRSF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check PLLWF's competition here
MDRSF vs PMEDF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, PMEDF has a market cap of 7.9M. Regarding current trading prices, MDRSF is priced at $100.00, while PMEDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas PMEDF's P/E ratio is -1.90. In terms of profitability, MDRSF's ROE is -0.00%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, MDRSF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check PMEDF's competition here
MDRSF vs USAQ Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, USAQ has a market cap of 7.3M. Regarding current trading prices, MDRSF is priced at $100.00, while USAQ trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas USAQ's P/E ratio is -16.11. In terms of profitability, MDRSF's ROE is -0.00%, compared to USAQ's ROE of +0.63%. Regarding short-term risk, MDRSF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check USAQ's competition here
MDRSF vs MDXHF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, MDXHF has a market cap of 6.9M. Regarding current trading prices, MDRSF is priced at $100.00, while MDXHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas MDXHF's P/E ratio is -2.10. In terms of profitability, MDRSF's ROE is -0.00%, compared to MDXHF's ROE of +0.58%. Regarding short-term risk, MDRSF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check MDXHF's competition here
MDRSF vs NGMDF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, NGMDF has a market cap of 5.9M. Regarding current trading prices, MDRSF is priced at $100.00, while NGMDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas NGMDF's P/E ratio is -2.58. In terms of profitability, MDRSF's ROE is -0.00%, compared to NGMDF's ROE of +0.34%. Regarding short-term risk, MDRSF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check NGMDF's competition here
MDRSF vs ODYY Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ODYY has a market cap of 5.5M. Regarding current trading prices, MDRSF is priced at $100.00, while ODYY trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ODYY's P/E ratio is -5.50. In terms of profitability, MDRSF's ROE is -0.00%, compared to ODYY's ROE of +0.18%. Regarding short-term risk, MDRSF is more volatile compared to ODYY. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check ODYY's competition here
MDRSF vs QLIS Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, MDRSF is priced at $100.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas QLIS's P/E ratio is 2.22. In terms of profitability, MDRSF's ROE is -0.00%, compared to QLIS's ROE of -0.60%. Regarding short-term risk, MDRSF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check QLIS's competition here
MDRSF vs RHNMF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, MDRSF is priced at $100.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, MDRSF's ROE is -0.00%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, MDRSF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RHNMF's competition here
MDRSF vs BIEL Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, BIEL has a market cap of 5.4M. Regarding current trading prices, MDRSF is priced at $100.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas BIEL's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is -0.00%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, MDRSF is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check BIEL's competition here
MDRSF vs ADMT Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ADMT has a market cap of 4.7M. Regarding current trading prices, MDRSF is priced at $100.00, while ADMT trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ADMT's P/E ratio is -7.00. In terms of profitability, MDRSF's ROE is -0.00%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, MDRSF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ADMT's competition here
MDRSF vs CYDX Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, CYDX has a market cap of 4.4M. Regarding current trading prices, MDRSF is priced at $100.00, while CYDX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas CYDX's P/E ratio is 1.10. In terms of profitability, MDRSF's ROE is -0.00%, compared to CYDX's ROE of +0.14%. Regarding short-term risk, MDRSF is more volatile compared to CYDX. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check CYDX's competition here
MDRSF vs VYCO Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, VYCO has a market cap of 3.7M. Regarding current trading prices, MDRSF is priced at $100.00, while VYCO trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas VYCO's P/E ratio is -11.00. In terms of profitability, MDRSF's ROE is -0.00%, compared to VYCO's ROE of +0.00%. Regarding short-term risk, MDRSF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check VYCO's competition here
MDRSF vs VANIW Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, MDRSF is priced at $100.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas VANIW's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is -0.00%, compared to VANIW's ROE of -2.94%. Regarding short-term risk, MDRSF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check VANIW's competition here
MDRSF vs FZMD Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, FZMD has a market cap of 3M. Regarding current trading prices, MDRSF is priced at $100.00, while FZMD trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas FZMD's P/E ratio is 1.33. In terms of profitability, MDRSF's ROE is -0.00%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, MDRSF is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check FZMD's competition here
MDRSF vs TBRIF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, TBRIF has a market cap of 2.4M. Regarding current trading prices, MDRSF is priced at $100.00, while TBRIF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas TBRIF's P/E ratio is -0.82. In terms of profitability, MDRSF's ROE is -0.00%, compared to TBRIF's ROE of +16.81%. Regarding short-term risk, MDRSF is more volatile compared to TBRIF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check TBRIF's competition here
MDRSF vs LLBO Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, LLBO has a market cap of 2.2M. Regarding current trading prices, MDRSF is priced at $100.00, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas LLBO's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is -0.00%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, MDRSF is less volatile compared to LLBO. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check LLBO's competition here
MDRSF vs ESMC Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ESMC has a market cap of 1.9M. Regarding current trading prices, MDRSF is priced at $100.00, while ESMC trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ESMC's P/E ratio is -12.50. In terms of profitability, MDRSF's ROE is -0.00%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, MDRSF is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ESMC's competition here
MDRSF vs VRSEF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, VRSEF has a market cap of 1.4M. Regarding current trading prices, MDRSF is priced at $100.00, while VRSEF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas VRSEF's P/E ratio is 0.14. In terms of profitability, MDRSF's ROE is -0.00%, compared to VRSEF's ROE of +1.00%. Regarding short-term risk, MDRSF is more volatile compared to VRSEF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check VRSEF's competition here
MDRSF vs KLYG Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, KLYG has a market cap of 1.3M. Regarding current trading prices, MDRSF is priced at $100.00, while KLYG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas KLYG's P/E ratio is -10.60. In terms of profitability, MDRSF's ROE is -0.00%, compared to KLYG's ROE of -1.40%. Regarding short-term risk, MDRSF is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check KLYG's competition here
MDRSF vs NUMD Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, NUMD has a market cap of 1.3M. Regarding current trading prices, MDRSF is priced at $100.00, while NUMD trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas NUMD's P/E ratio is 1.53. In terms of profitability, MDRSF's ROE is -0.00%, compared to NUMD's ROE of +0.23%. Regarding short-term risk, MDRSF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check NUMD's competition here
MDRSF vs UAHC Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, UAHC has a market cap of 1.1M. Regarding current trading prices, MDRSF is priced at $100.00, while UAHC trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas UAHC's P/E ratio is 0.53. In terms of profitability, MDRSF's ROE is -0.00%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, MDRSF is less volatile compared to UAHC. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check UAHC's competition here
MDRSF vs ELXMF Comparison February 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.2B. In comparison, ELXMF has a market cap of 541.2K. Regarding current trading prices, MDRSF is priced at $100.00, while ELXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of -1666.67, whereas ELXMF's P/E ratio is -0.06. In terms of profitability, MDRSF's ROE is -0.00%, compared to ELXMF's ROE of -0.50%. Regarding short-term risk, MDRSF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for MDRSF.Check ELXMF's competition here